Solicitation of Nominations for Appointment to the Lead Exposure and Prevention Advisory Committee, 7478-7479 [2018-03462]
Download as PDF
<![CDATA[
7478
Federal Register / Vol. 83, No. 35 / Wednesday, February 21, 2018 / Notices
the U.S. loan markets. A portion of each
survey typically covers special topics of
timely interest. There is the option to
survey other types of respondents (such
as other depository institutions, bank
holding companies, or other financial
entities) should the need arise. The FR
2018 survey provides crucial
information for monitoring and
understanding the evolution of lending
practices at banks and developments in
credit markets.
Legal authorization and
confidentiality: The Board’s Legal
Division has determined that the Senior
Loan Officer Opinion Survey on Bank
Lending Practices is authorized by
Sections 2A, 11, and 12A of the Federal
Reserve Act (12 U.S.C. 225a, 248(a), and
263) and Section 7 of the International
Banking Act (12 U.S.C. 3105(c)(2)) and
is voluntary. Individual survey
responses from each respondent can be
held confidential under section (b)(4) of
the Freedom of Information Act (5
U.S.C. 552(b)(4)). However, certain data
from the survey is reported in aggregate
form and the information in aggregate
form is made publicly available and not
considered confidential.
Board of Governors of the Federal Reserve
System, February 15, 2018.
Ann E. Misback,
Secretary of the Board.
[FR Doc. 2018–03532 Filed 2–20–18; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Lead Exposure and
Prevention Advisory Committee
ACTION:
Notice.
The Centers for Disease
Control and Prevention (CDC) is
soliciting nominations for membership
on the LEPAC. The LEPAC consists of
15 Federal and non-Federal experts in
fields associated with lead screening,
the prevention of lead exposure, and
services for individuals and
communities affected by lead exposure.
Nominations are being sought for
individuals who have expertise and
qualifications necessary to contribute to
the accomplishment of the committee’s
objectives. Nominees will be selected
based on expertise in the fields of
epidemiology, toxicology, mental
health, pediatrics, early childhood
education, special education, diet and
nutrition, and environmental health.
daltland on DSKBBV9HB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:57 Feb 20, 2018
Jkt 244001
Members may be invited to serve for
three-year terms. Selection of members
is based on candidates’ qualifications to
contribute to the accomplishment of
LEPAC objectives.
DATES: Nominations for membership on
the LEPAC must be received no later
than April 15, 2018. Packages received
after this time will not be considered for
the current membership cycle.
ADDRESSES: All nominations should be
mailed to Ms. Perri Ruckart, MPH,
Centers for Disease Control and
Prevention, 4770 Buford Highway, MS
F–58, Atlanta, GA 30341, emailed
(recommended) to PRuckart@cdc.gov, or
faxed to 770–488–3635.
FOR FURTHER INFORMATION CONTACT: Ms.
Perri Ruckart, MPH, Designated Federal
Officer, National Center for
Environmental Health, Centers for
Disease Control and Prevention, 4770
Buford Hwy. NE, Mailstop F–58,
Atlanta, GA 30341, 770–488–3808,
PRuckart@cdc.gov.
SUPPLEMENTARY INFORMATION: The
members of this committee are selected
by the Secretary of the U.S. Department
of Health and Human Services (HHS).
The committee advises the Secretary,
HHS and the Director, Centers for
Disease Control and Prevention/
Administrator, Agency for Toxic
Substances and Disease Registry on a
range of activities to include: (1) Review
of the Federal programs and services
available to individuals and
communities exposed to lead; (2) review
of the current research on lead exposure
to identify additional research needs; (3)
review of and identification of best
practices, or the need for best practices
regarding lead screening and the
prevention of lead exposure; (4)
identification of effective services,
including services relating to healthcare,
education, and nutrition for individuals
and communities affected by lead
exposure and lead poisoning, including
in consultation with, as appropriate, the
lead exposure registry as established in
Public Law 114–322 Section 2203(b) (42
U.S.C. 300j–27); and (5) undertaking of
any other review or activities that the
Secretary determines to be appropriate.
Annually as determined necessary by
the Secretary or as required by Congress,
the committee shall submit a report to
include: (1) An evaluation of the
effectiveness of the Federal programs
and services available to individuals
and communities exposed to lead; (2) an
evaluation of additional lead exposure
research needs; (3) an assessment of any
effective screening methods or best
practices used or developed to prevent
or screen for lead exposure; (4) input
and recommendations for improved
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
access to effective services relating to
health care, education, or nutrition for
individuals and communities impacted
by lead exposure; and (5) any other
recommendations for communities
affected by lead exposure, as
appropriate.
At least half of the committee will
consist of Federal representatives from a
range of agencies that may include the
Department of Housing and Urban
Development; the Environmental
Protection Agency; the Consumer
Product Safety Commission; the Centers
for Medicare and Medicaid Services; the
Health Resources and Services
Administration; the Food and Drug
Administration; the U.S. Department of
Agriculture; the Occupational Safety
and Health Administration; the National
Institute of Environmental Health
Sciences; the U.S. Geological Survey;
and such additional federal, state, tribal,
and local public and private officials as
the Secretary deems necessary for the
committee to carry out its function. The
rest of the committee will consist of
non-Federal members. Only non-Federal
members are being solicited with this
announcement.
The U.S. Department of Health and
Human Services policy stipulates that
committee membership be balanced in
terms of points of view represented and
the committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens
and cannot be full-time employees of
the U.S. Government. Current
participation on federal workgroups or
prior experience serving on a federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Committee
members are Special Government
Employees, requiring the filing of
financial disclosure reports at the
beginning and annually during their
terms. CDC reviews potential candidates
for LEPAC membership each year, and
provides a slate of nominees for
consideration to the Secretary of HHS
for final selection. HHS notifies selected
candidates of their appointment as soon
as the HHS selection process is
completed. Note that the need for
different expertise varies from year to
year and a candidate who is not selected
in one year may be reconsidered in a
subsequent year. Nominees must be U.S.
citizens, and cannot be full-time
employees of the U.S. Government.
E:\FR\FM\21FEN1.SGM
21FEN1
Federal Register / Vol. 83, No. 35 / Wednesday, February 21, 2018 / Notices
Candidates should submit the following
items:
• Current curriculum vitae, including
complete contact information
(telephone numbers, mailing address,
email address).
• A least one letter of
recommendation from person(s) not
employed by the U.S. Department of
Health and Human Services.
(Candidates may submit letter(s) from
current HHS employees if they wish,
but at least one letter must be submitted
by a person not employed by an HHS
agency (e.g., CDC, NIH, FDA, etc.).
Nominations may be submitted by the
candidate him- or herself or by the
person/organization recommending the
candidate.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2018–03462 Filed 2–20–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10656 and CMS–
10277]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
daltland on DSKBBV9HB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
19:57 Feb 20, 2018
Jkt 244001
7479
publishing this notice that summarizes
the following proposed collection(s) of
information for public comment:
1. Type of Information Collection
Request: New collection of information
request; Title of Information Collection:
Evaluation of the Partnership for
Patients (PfP) 3.0; Use: In the summer of
2015, the Centers for Medicare &
Medicaid Services (CMS) Administrator
approved the plans for integration of the
Partnership for Patients (PfP) Hospital
DATES: Comments on the collection(s) of
Engagement Network (HEN) model test
information must be received by the
with the Quality Improvement NetworkOMB desk officer by March 23, 2018.
Quality Improvement Organization
ADDRESSES: When commenting on the
(QIN–QIO) program. This is consistent
proposed information collections,
with the Agency’s intention for further
please reference the document identifier integration to maximize the strengths of
or OMB control number. To be assured
the QIO program and PfP HENs to
consideration, comments and
sustain and expand current national
recommendations must be received by
reductions in in-patient harm and 30the OMB desk officer via one of the
day readmissions. The alignment of the
following transmissions: OMB, Office of two programs permits the systematic
Information and Regulatory Affairs,
use of innovative patient safety
Attention: CMS Desk Officer, Fax
practices at a national scale.
Number: (202) 395–5806 OR, Email:
Under this initiative, CMS has
awarded multiple contracts to Hospital
OIRA_submission@omb.eop.gov.
Improvement Innovation Networks
To obtain copies of a supporting
(HIINs), formerly known as HENs, to
statement and any related forms for the
engage the hospital, provider, and
proposed collection(s) summarized in
broader caregiver communities to
this notice, you may make your request
implement well-tested and measured
using one of following:
best practices. The end result of the
1. Access CMS’ website address at
website address at https://www.cms.gov/ overall initiative is the anticipated
reduction in preventable hospital-based
Regulations-and-Guidance/Legislation/
harm and readmissions for patients.
PaperworkReductionActof1995/PRAThe PfP initiative is a public-private
Listing.html.
partnership dedicated to the
2. Email your request, including your
improvement of health care quality,
address, phone number, OMB number,
safety, and affordability. CMS, working
and CMS document identifier, to
with hospitals, providers, and the
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at broader caregiver community, aims to
implement and disseminate best
(410) 786–1326.
practices on a national scale to reduce
FOR FURTHER INFORMATION CONTACT:
hospital acquired conditions (HACs)
William Parham at (410) 786–4669.
and all-cause readmissions. Through the
SUPPLEMENTARY INFORMATION: Under the
PfP model, which was initiated in April
Paperwork Reduction Act of 1995 (PRA) 2011, CMS fostered rapid learning
(44 U.S.C. 3501–3520), federal agencies
among a nationwide community of
must obtain approval from the Office of
practice, resulting in major strides in
Management and Budget (OMB) for each patient safety and engagement by
collection of information they conduct
patients and families.
A mixed methods approach to
or sponsor. The term ‘‘collection of
answering the PfP HIIN evaluation
information’’ is defined in 44 U.S.C.
questions includes three primary data
3502(3) and 5 CFR 1320.3(c) and
collection activities, as follows: Hospital
includes agency requests or
requirements that members of the public Survey on Prevention of Adverse Events
submit reports, keep records, or provide and Reduction of Readmissions, HIIN
Data Quality Assurance (QA) Survey
information to a third party. Section
and Qualitative Discussions with HIIN
3506(c)(2)(A) of the PRA (44 U.S.C.
leaders and Other Support Contractors.
3506(c)(2)(A)) requires federal agencies
The data collected will provide us
to publish a 30-day notice in the
feedback to focus efforts to improve the
Federal Register concerning each
effectiveness and efficiency of the HIIN
proposed collection of information,
initiative. As we draft future HIIN and
including each proposed extension or
QIO contracts, information from
reinstatement of an existing collection
hospitals about HIIN influence on their
of information, before submitting the
care processes will be used together
collection to OMB for approval. To
with follow-up input from stakeholders
comply with this requirement, CMS is
information, including the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected; and the use
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
E:\FR\FM\21FEN1.SGM
21FEN1
]]>Agencies
[Federal Register Volume 83, Number 35 (Wednesday, February 21, 2018)]
[Notices]
[Pages 7478-7479]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-03462]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to the Lead Exposure
and Prevention Advisory Committee
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) is
soliciting nominations for membership on the LEPAC. The LEPAC consists
of 15 Federal and non-Federal experts in fields associated with lead
screening, the prevention of lead exposure, and services for
individuals and communities affected by lead exposure. Nominations are
being sought for individuals who have expertise and qualifications
necessary to contribute to the accomplishment of the committee's
objectives. Nominees will be selected based on expertise in the fields
of epidemiology, toxicology, mental health, pediatrics, early childhood
education, special education, diet and nutrition, and environmental
health. Members may be invited to serve for three-year terms. Selection
of members is based on candidates' qualifications to contribute to the
accomplishment of LEPAC objectives.
DATES: Nominations for membership on the LEPAC must be received no
later than April 15, 2018. Packages received after this time will not
be considered for the current membership cycle.
ADDRESSES: All nominations should be mailed to Ms. Perri Ruckart, MPH,
Centers for Disease Control and Prevention, 4770 Buford Highway, MS F-
58, Atlanta, GA 30341, emailed (recommended) to [email protected], or
faxed to 770-488-3635.
FOR FURTHER INFORMATION CONTACT: Ms. Perri Ruckart, MPH, Designated
Federal Officer, National Center for Environmental Health, Centers for
Disease Control and Prevention, 4770 Buford Hwy. NE, Mailstop F-58,
Atlanta, GA 30341, 770-488-3808, [email protected].
SUPPLEMENTARY INFORMATION: The members of this committee are selected
by the Secretary of the U.S. Department of Health and Human Services
(HHS). The committee advises the Secretary, HHS and the Director,
Centers for Disease Control and Prevention/Administrator, Agency for
Toxic Substances and Disease Registry on a range of activities to
include: (1) Review of the Federal programs and services available to
individuals and communities exposed to lead; (2) review of the current
research on lead exposure to identify additional research needs; (3)
review of and identification of best practices, or the need for best
practices regarding lead screening and the prevention of lead exposure;
(4) identification of effective services, including services relating
to healthcare, education, and nutrition for individuals and communities
affected by lead exposure and lead poisoning, including in consultation
with, as appropriate, the lead exposure registry as established in
Public Law 114-322 Section 2203(b) (42 U.S.C. 300j-27); and (5)
undertaking of any other review or activities that the Secretary
determines to be appropriate.
Annually as determined necessary by the Secretary or as required by
Congress, the committee shall submit a report to include: (1) An
evaluation of the effectiveness of the Federal programs and services
available to individuals and communities exposed to lead; (2) an
evaluation of additional lead exposure research needs; (3) an
assessment of any effective screening methods or best practices used or
developed to prevent or screen for lead exposure; (4) input and
recommendations for improved access to effective services relating to
health care, education, or nutrition for individuals and communities
impacted by lead exposure; and (5) any other recommendations for
communities affected by lead exposure, as appropriate.
At least half of the committee will consist of Federal
representatives from a range of agencies that may include the
Department of Housing and Urban Development; the Environmental
Protection Agency; the Consumer Product Safety Commission; the Centers
for Medicare and Medicaid Services; the Health Resources and Services
Administration; the Food and Drug Administration; the U.S. Department
of Agriculture; the Occupational Safety and Health Administration; the
National Institute of Environmental Health Sciences; the U.S.
Geological Survey; and such additional federal, state, tribal, and
local public and private officials as the Secretary deems necessary for
the committee to carry out its function. The rest of the committee will
consist of non-Federal members. Only non-Federal members are being
solicited with this announcement.
The U.S. Department of Health and Human Services policy stipulates
that committee membership be balanced in terms of points of view
represented and the committee's function. Appointments shall be made
without discrimination on the basis of age, race, ethnicity, gender,
sexual orientation, gender identity, HIV status, disability, and
cultural, religious, or socioeconomic status. Nominees must be U.S.
citizens and cannot be full-time employees of the U.S. Government.
Current participation on federal workgroups or prior experience serving
on a federal advisory committee does not disqualify a candidate;
however, HHS policy is to avoid excessive individual service on
advisory committees and multiple committee memberships. Committee
members are Special Government Employees, requiring the filing of
financial disclosure reports at the beginning and annually during their
terms. CDC reviews potential candidates for LEPAC membership each year,
and provides a slate of nominees for consideration to the Secretary of
HHS for final selection. HHS notifies selected candidates of their
appointment as soon as the HHS selection process is completed. Note
that the need for different expertise varies from year to year and a
candidate who is not selected in one year may be reconsidered in a
subsequent year. Nominees must be U.S. citizens, and cannot be full-
time employees of the U.S. Government.
[[Page 7479]]
Candidates should submit the following items:
Current curriculum vitae, including complete contact
information (telephone numbers, mailing address, email address).
A least one letter of recommendation from person(s) not
employed by the U.S. Department of Health and Human Services.
(Candidates may submit letter(s) from current HHS employees if they
wish, but at least one letter must be submitted by a person not
employed by an HHS agency (e.g., CDC, NIH, FDA, etc.).
Nominations may be submitted by the candidate him- or herself or by
the person/organization recommending the candidate.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities for
both the Centers for Disease Control and Prevention, and the Agency for
Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2018-03462 Filed 2-20-18; 8:45 am]
BILLING CODE 4163-18-P
